Effect of Antibiotic Treatment Delay on Therapeutic Outcome of Experimental Acute Otitis Media Caused by Streptococcus Pneumoniae Strains with Different Susceptibilities to Amoxicillin

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2004 Feb 26

PMID 14982776

Citations 2

Authors

Araceli Parra

Carmen Ponte

Carlos Cenjor

Carmen Martinez-Marin

Francisco Soriano

Affiliations

Soon will be listed here.

Abstract

The effect of delayed administration of amoxicillin on the course of acute otitis media (AOM) caused by two Streptococcus pneumoniae strains with different susceptibilities to amoxicillin (MICs of 0.016 and 1 microg/ml for strains A and B, respectively) was evaluated in the gerbil model. The organisms were inoculated by transbullar challenge into the middle ear, and antibiotic treatment was administered at various times thereafter. The bacteriological and clinical efficacies of treatment diminished significantly with the delay of antibiotic administration. The bacterial eradication rates when antibiotic treatment was started at 2, 5, 8, 18, and 21 h post-bacterial inoculation were different for both strains (95, 95, 90, 55, and 55% for strain A and 95, 95, 65, 10, and 0% for strain B). Results of further experiments using strain B with higher antibiotic doses and numbers of administrations and different follow-up times indicate that the failures observed with the delayed administration were not related to the bacterial burden, selection of antibiotic-resistant mutants, or inadequate pharmacodynamic parameters. Such failures may be related to the metabolic bacterial status. The delayed amoxicillin treatment of AOM caused by S. pneumoniae may lead to therapeutic failures, mainly when organisms with diminished antibiotic susceptibility are involved.

Citing Articles

Biological Preparation of Chitosan-Loaded Silver Nanoparticles: Study of Methylene Blue Adsorption as Well as Antibacterial Properties under Light.

Ren W, Tang Q, Cao H, Wang L, Zheng X ACS Omega. 2023; 8(25):22998-23007.

PMID: 37396237 PMC: 10308547. DOI: 10.1021/acsomega.3c02111.

Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs differ.

Gracia M, Martinez-Marin C, Huelves L, Gimenez M, Aguilar L, Carcas A Antimicrob Agents Chemother. 2005; 49(3):996-1001.

PMID: 15728894 PMC: 549246. DOI: 10.1128/AAC.49.3.996-1001.2005.

References

Ginsburg C, McCracken Jr G, Nelson J . Pharmacology of oral antibiotics used for treatment of otitis media and tonsillopharyngitis in infants and children. Ann Otol Rhinol Laryngol Suppl. 1981; 90(3 Pt 3):37-43. DOI: 10.1177/00034894810903s210. View

Dowell S, Butler J, Giebink G, Jacobs M, Jernigan D, Musher D . Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999; 18(1):1-9. View

Parra A, Ponte C, Cenjor C, Gimenez M, Aguilar L, Soriano F . Optimal dose of amoxicillin in treatment of otitis media caused by a penicillin-resistant pneumococcus strain in the gerbil model. Antimicrob Agents Chemother. 2002; 46(3):859-62. PMC: 127470. DOI: 10.1128/AAC.46.3.859-862.2002. View

FROOM J, Culpepper L, Jacobs M, DeMelker R, Green L, van Buchem L . Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ. 1997; 315(7100):98-102. PMC: 2127061. DOI: 10.1136/bmj.315.7100.98. View

Little P, Gould C, Williamson I, Moore M, Warner G, Dunleavey J . Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ. 2001; 322(7282):336-42. PMC: 26576. DOI: 10.1136/bmj.322.7282.336. View

Barry B, Gehanno P, Pocidalo J . Effect of increased dosages of amoxicillin in treatment of experimental middle ear otitis due to penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother. 1993; 37(8):1599-603. PMC: 188026. DOI: 10.1128/AAC.37.8.1599. View

Widmer A, Frei R, Rajacic Z, Zimmerli W . Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis. 1990; 162(1):96-102. DOI: 10.1093/infdis/162.1.96. View

van Zuijlen D, Schilder A, van Balen F, Hoes A . National differences in incidence of acute mastoiditis: relationship to prescribing patterns of antibiotics for acute otitis media?. Pediatr Infect Dis J. 2001; 20(2):140-4. DOI: 10.1097/00006454-200102000-00004. View

Eagle H . Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med. 1952; 13(4):389-99. DOI: 10.1016/0002-9343(52)90293-3. View

10.

Soriano F, Parra A, Cenjor C, Nieto E, Garcia-Calvo G, Gimenez M . Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model. J Infect Dis. 2000; 181(2):646-52. DOI: 10.1086/315237. View

11.

Cenjor C, Ponte C, Parra A, Nieto E, Garcia-Calvo G, Gimenez M . In vivo efficacies of amoxicillin and cefuroxime against penicillin-resistant Streptococcus pneumoniae in a gerbil model of acute otitis media. Antimicrob Agents Chemother. 1998; 42(6):1361-4. PMC: 105604. DOI: 10.1128/AAC.42.6.1361. View

12.

Teele D, Klein J, Rosner B, Bratton L, FISCH G, Mathieu O . Middle ear disease and the practice of pediatrics. Burden during the first five years of life. JAMA. 1983; 249(8):1026-9. View

13.

Barry B, Bauchet J, Faurisson F, Gehanno P, Pocidalo J, Carbon C . Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996; 40(9):1977-82. PMC: 163458. DOI: 10.1128/AAC.40.9.1977. View

14.

Gerber A, Greter U, Segessenmann C, Kozak S . The impact of the pre-treatment interval on antimicrobial efficacy in a biological model. J Antimicrob Chemother. 1993; 31 Suppl D:29-39. DOI: 10.1093/jac/31.suppl_d.29. View

15.

Guillemot D, Carbon C, Balkau B, Geslin P, Lecoeur H, Vauzelle-Kervroedan F . Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA. 1998; 279(5):365-70. DOI: 10.1001/jama.279.5.365. View

16.

Ponte C, Cenjor C, Parra A, Nieto E, Garcia-Calvo G, Gimenez M . Antimicrobial treatment of an experimental otitis media caused by a beta-lactamase positive isolate of Haemophilus influenzae. J Antimicrob Chemother. 1999; 44(1):85-90. DOI: 10.1093/jac/44.1.85. View

17.

Hendley J . Clinical practice. Otitis media. N Engl J Med. 2002; 347(15):1169-74. DOI: 10.1056/NEJMcp010944. View

18.

Van Hare G, Shurin P, Marchant C, Cartelli N, Johnson C, Fulton D . Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis. 1987; 9(1):16-27. DOI: 10.1093/clinids/9.1.16. View

19.

Ehrlich G, Veeh R, Wang X, Costerton J, Hayes J, Hu F . Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA. 2002; 287(13):1710-5. DOI: 10.1001/jama.287.13.1710. View

20.

Pichichero M, Pichichero C . Persistent acute otitis media: I. Causative pathogens. Pediatr Infect Dis J. 1995; 14(3):178-83. DOI: 10.1097/00006454-199503000-00002. View